Product logins

Find logins to all Clarivate products below.


Large-Joint Reconstructive Implants | Market Insights | Latin America (Supplemental) | 2024

Long-term growth of the large-joint reconstruction market will be driven by the uptake of novel technologies such as patient-conforming and 3-D printed implants, smart implants, robotic- and navigation-assisted surgeries, and minimally invasive techniques. In addition, although the increasing shift of procedures to the ASC and outpatient settings will place downward pressure on ASPs, this trend will also make procedures less expensive for patients, driving procedure volume and overall market growth.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for large-joint reconstructive implants in the US from 2019 through 2033.

Related Medtech Insights Reports

Report
Laparoscopic Devices – Market Insights – Latin America
The Latin American laparoscopic device market will experience steady moderate growth through 2035, supported by the gradual expansion of MIS volumes and selective adoption of highervalue…
Report
Aesthetic Injectables – Market Insights – Latin America
The Latin American aesthetic injectables market will expand through 2035, driven by ongoing product innovation and differentiation strategies among key competitors, as well as the increasing…
Report
Urological Devices – Market Insights – Latin America
The Latin American urological device market will continue to expand through 2034, driven by the rising prevalence of kidney stones and UI, aging populations, and growing patient awareness of…
Report
Interventional Oncology Devices – Market Insights – Latin America
The Latin American interventional oncology device market will see moderate growth through 2034, driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of…
Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…